Financials

  • Market Capitalization 587.04 M
  • Employee 131
  • Founded 2018
  • CEO Jonathan Drachman M.D.
  • Website www.neurogene.com
  • Headquarter New York, United States
  • FIGI BBG005Y0QDK1
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-4.86
Fiyat/satışlar oranı

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
2804
FDMT
4D Molecular Therapeutics, Inc. - Common Stock
11.42 USD+1.06%-8.93%+26.33%+1.06%596.99 M USD
2814
IMMX
Immix Biopharma, Inc. - Common Stock
10.83 USD+2.95%-0.46%+26.22%+273.45%589.28 M USD
2833
DRUG
Bright Minds Biosciences Inc. - common stock
75.40 USD-0.70%+15.10%+21.91%+190.45%575.74 M USD
2836
ALT
Altimmune, Inc. - Common Stock
2.95 USD-1.34%-1.99%+12.60%-31.24%573.70 M USD

Haberler